Technology: BGF’s investment in ClearSphere 

Armstrong provided commercial due diligence to BGF on its investment in ClearSphere, a provider of cleanroom and containment solutions for pharmaceutical, medical device, healthcare and industrial clients. 

Founded in 1989, Cork-based ClearSphere has become a market leader in delivering high-quality, integrated controlled environment systems to blue-chip clients, such as Pfizer, Abbott, Hovione, Tallaght University Hospital and the National Children’s Hospital.  

The investment will allow ClearSphere to accelerate its growth strategy, expand its capabilities, invest in innovation and scale its operations into new regions, including Northern Ireland and the UK. 

Armstrong carried out focused CDD, including market and competitor analysis, along with detailed customer and supplier interviews.  

Matt McNally, Director at Armstrong, said “ClearSphere operates in an attractive, growing segment of the market and has built a strong reputation in a clearly defined niche. Customer feedback was very good, and the business is well placed to grow with BGF’s support.” 

If you are interested in talking to Armstrong about similar opportunities in this sector, please contact: 

Matt McNally

mmcnally@armstrong-ts.com
+44 7894 736 523